About Caltag Medsystems
Caltag Medsystems is a company based in Buckingham (United Kingdom) founded in 2001 by Tim Almond. It operates as a B2B. Caltag Medsystems offers products and services including Antibodies, Assays and Kits, Biological Samples, and Cell Culture. Caltag Medsystems operates in a competitive market with competitors including Nautilus Biotechnology, KBI Biopharma, ProteinSimple, Somalogic and Amunix, among others.
- Headquarter Buckingham, United Kingdom
- Founders Tim Almond
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website caltagmedsystems.co.uk
- Social LinkedIn X Facebook YouTube
- Legal Name Caltag Medsystems Limited
- Date of Incorporation 16 Feb, 2001
- Jurisdiction BUCKINGHAM, BUCKINGHAMSHIRE
Products & Services of Caltag Medsystems
Caltag Medsystems offers a comprehensive portfolio of products and services, including Antibodies, Assays and Kits, Biological Samples, and Cell Culture.
Products for detecting specific proteins in biological research.
Kits for performing immunoassays and cellular assays.
Samples including cells and tissues for research applications.
Media and tools for growing and maintaining cell cultures.
Apps and channels of Caltag Medsystems
its YouTube channel CaltagMedsystems has 24 subscribers.
People of Caltag Medsystems
1 people are tracked at Caltag Medsystems (1 in leadership).
| Name | Role | Group |
|---|---|---|
Tim Almond | Founder, CEO | Leadership |
Complete people profiles for Caltag Medsystems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Caltag Medsystems
Caltag Medsystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nautilus Biotechnology, KBI Biopharma, ProteinSimple, Somalogic and Amunix, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nautilus.bio | 2016 | Seattle, United States | $103.26M | 134 | A proteomics platform is developed for analyzing the human proteome. | |
| kbibiopharma.com | 1996 | Durham, United States | $18.29M | 1,243 | Provider of protein formulation, process & cell line development, and cGMP services | |
| proteinsimple.com | 2004 | San Jose, United States | $114.29M | 157 | Provider tools to help researchers with protein analysis | |
| somalogic.com | 1999 | Boulder, United States | $663.99M | 319 | Protein-based assays are developed for life science research. | |
| amunix.com | 2006 | Mountain View, United States | $200.59M | 82 | Peptide-based therapeutics are developed for cancers and immune disorders. | |
| dynamic-biosensors.com | 2011 | Planegg, Germany | $5.83M | 51 | Label-free solutions for molecular interactions and biophysical analysis are provided. | |
| eirgenix.com | 2012 | Taipei, Taiwan | $90.58M | – | Biologics development and manufacturing services are offered by EirGenix. | |
| biognosys.com | 2008 | Schlieren, Switzerland | $9.13M | – | Proteomics services are delivered via discovery and targeted platforms. | |
| elektrofi.com | 2016 | Boston, United States | $152.25M | 71 | Digital platform transforming the delivery of biologic medicines | |
| arzeda.com | 2008 | Seattle, United States | $94.96M | 66 | Synthetic enzymes are designed using computational technology for industrial applications. |
Detailed competitors of Caltag Medsystems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Caltag Medsystems
Websites that share an audience with Caltag Medsystems (caltagmedsystems.co.uk).
Websites whose visitors overlap most with Caltag Medsystems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioscience.co.uk | 100% | 58K | #534,137 | View details | |
| cellntec.com | 99% | 2.8K | #6,513,861 | View details | |
| allcells.com | 88% | 4.9K | #3,979,970 | View details | |
| bioz.com | 81% | 62.4K | #597,932 | View details | |
| biosynth.com | 80% | 211.7K | #204,110 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Caltag Medsystems
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Caltag Medsystems
10 companies that operate in the same segment as Caltag Medsystems (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Caltag Medsystems
Caltag Medsystems was founded in 2001.
Caltag Medsystems is headquartered in Buckingham, United Kingdom. It is registered at Buckingham, Buckinghamshire, United Kingdom.
Tim Almond is the current CEO of Caltag Medsystems. They have also founded this company.
Caltag Medsystems is a distributor of life science solutions, offering products such as antibodies, assays, kits, and cell culture items. They source from various suppliers and provide support to scientists, ensuring quality and competitive pricing. Based in Buckingham, UK, they assist in product sourcing and handle complex logistics for research institutions and professionals.
Caltag Medsystems's top competitors include Somalogic, Nautilus Biotechnology and KBI Biopharma.
Caltag Medsystems offers Antibodies, Assays and Kits, Biological Samples, and Cell Culture.
Caltag Medsystems operates through Caltag Medsystems Limited.